Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
13 hedge funds and large institutions have $108K invested in Histogen Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
49% less capital invested
Capital invested by funds: $211K → $108K (-$103K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$14.4K |
| 2 |
SF
Synovus Financial
Columbus,
Georgia
|
+$9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.39K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$32K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.67K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$2.09K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$124 |
HSTO Hedge Fund Activity: Q2 2023 in Review
13 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2023, worth a combined $108K — down 49% from $211K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HSTO and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $14.4K. The largest seller was Millennium Management, exiting entirely with an estimated $32K sold.
- 13 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2023, down from 14 in Q1 2023.
- Funds reported $108K of Histogen Inc. Common Stock stock for Q2 2023, down 49% quarter-over-quarter.
- 2 funds opened new Histogen Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of -1 holder.
- The largest Histogen Inc. Common Stock buyer in Q2 2023 was Morgan Stanley, an estimated $14.4K added.
- The largest Histogen Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $32K sold.
Based on aggregated 13F filings for Q2 2023.